SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov 23, 2022--
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conference:
Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/
About Omnicell
Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Healthcare facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks and Omnicell One is a trademark of Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source version on businesswire.com:https://www.businesswire.com/news/home/20221123005087/en/
CONTACT: Kathleen Nemeth
Senior Vice President, Investor Relations
Omnicell
ir@omnicell.com
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SOFTWARE PRACTICE MANAGEMENT TELEMEDICINE/VIRTUAL MEDICINE PHARMACEUTICAL INTERNET HEALTH DATA MANAGEMENT TECHNOLOGY
SOURCE: Omnicell, Inc.
Copyright Business Wire 2022.
PUB: 11/23/2022 04:01 PM/DISC: 11/23/2022 04:02 PM
http://www.businesswire.com/news/home/20221123005087/en